1. Measurements of the center-of-mass energies of collisions at BESIII *Supported in part by National Key Research and Development Program of China (2020YFA0406300, 2020YFA0406400); National Natural Science Foundation of China (NSFC) (11625523, 11635010, 11735014, 11822506, 11835012, 11935015, 11935016, 11935018, 11961141012); the Chinese Academy of Sciences (CAS) Large-Scale Scientific Facility Program; Joint Large-Scale Scientific Facility Funds of the NSFC and CAS (U1732263, U1832207); CAS Key Research Program of Frontier Sciences (QYZDJ-SSW-SLH003, QYZDJ-SSW-SLH040); 100 Talents Program of CAS; INPAC and Shanghai Key Laboratory for Particle Physics and Cosmology; ERC (758462); European Union Horizon 2020 research and innovation programme (Marie Sklodowska-Curie grant agreement No 894790); German Research Foundation DFG (443159800), Collaborative Research Center CRC 1044, FOR 2359, FOR 2359, GRK 214; Istituto Nazionale di Fisica Nucleare, Italy; Ministry of Development of Turkey (DPT2006K-120470); National Science and Technology fund; Olle Engkvist Foundation (200-0605); STFC (United Kingdom); The Knut and Alice Wallenberg Foundation (Sweden) (2016.0157); The Royal Society, UK (DH140054, DH160214); The Swedish Research Council; U. S. Department of Energy (DE-FG02-05ER41374, DE-SC-0012069). (October 2021) Authors: Ablikim, M.; Achasov, M. N.; Adlarson, P.; Ahmed, S.; Albrecht, M.; Aliberti, R.; Amoroso, A.; An, M. R.; An, Q.; Bai, X. H.; Bai, Y.; Bakina, O.; Baldini Ferroli, R.; Balossino, I.; Ban, Y.; Begzsuren, K.; Berger, N.; Bertani, M.; Bettoni, D.; Bianchi, F. Journal: Chinese physics C Issue: Volume 45:Number 10(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II study of the American Brachytherapy Society guidelines for the use of high–dose rate brachytherapy in the treatment of cervical carcinoma: is 45–50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high–dose rate brachytherapy tolerable?. Issue 1 (1st January 2006) Authors: Shakespeare, T. P.; Lim, K. H.C.; Lee, K. M.; Back, M. F.; Mukherjee, R.; Lu, J. D. Journal: International journal of gynecological cancer Issue: Volume 16:Issue 1(2006) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0270 5 Year Safety, Efficacy, and Radiographic Data in Patients with Active Psoriatic Arthritis Treated with Golimumab: Long-Term Extension Results of the Randomized, Placebo-Controlled Study Go-Reveal. (23rd January 2014) Authors: Kavanaugh, A.; van der Heijde, D.; McInnes, I.; Mease, P.; Krueger, G. G.; Gladman, D.; Zhou, Y.; Lu, J. D.; Xu, Z.; Noonan, L.; Beutler, A. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A674 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0486 Early MRI Measures Independently Predict 1- and 2- Year X-Ray Progression: Results from a Large Clinical Trial. (23rd January 2014) Authors: Baker, J.; Østergaard, M.; Emery, P.; Hsia, E. C.; Lu, J. D.; Baker, D.; Conaghan, P. G. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A746 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗